DAG1 | Dystroglycan 1 (dystrophin-associated glycoprotein 1) | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DBH | Dopamine beta-hydroxylase (dopamine beta-monooxygenase) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DDOST | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DDX17 | DEAD (Asp-Glu-Ala-Asp) box helicase 17 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
DHRS7 | Dehydrogenase/reductase (SDR family) member 7 | Predicted secreted proteins
| | | | | Expressed in all |
DIABLO | Diablo, IAP-binding mitochondrial protein | Disease related genes Mitochondrial proteins Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DNAJB11 | DnaJ (Hsp40) homolog, subfamily B, member 11 | Predicted secreted proteins
| | | | | Expressed in all |
DNAJC3 | DnaJ (Hsp40) homolog, subfamily C, member 3 | Predicted secreted proteins
| | | | | Expressed in all |
DNASE1 | Deoxyribonuclease I | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
DSG2 | Desmoglein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
DYNLT3 | Dynein, light chain, Tctex-type 3 | Predicted secreted proteins
| | | | | Expressed in all |
EBI3 | Epstein-Barr virus induced 3 | Predicted secreted proteins
| | | | | Tissue enriched |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EHMT2 | Euchromatic histone-lysine N-methyltransferase 2 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
EIF3F | Eukaryotic translation initiation factor 3, subunit F | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
EPDR1 | Ependymin related 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERAP2 | Endoplasmic reticulum aminopeptidase 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ERLIN1 | ER lipid raft associated 1 | Predicted secreted proteins
| | | | | Expressed in all |
F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FAM177A1 | Family with sequence similarity 177, member A1 | Predicted secreted proteins
| | | | | Expressed in all |
FAM213A | Family with sequence similarity 213, member A | Predicted secreted proteins
| | | | | Expressed in all |
FBLN1 | Fibulin 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FGB | Fibrinogen beta chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FHL1 | Four and a half LIM domains 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
FKBP10 | FK506 binding protein 10, 65 kDa | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Mixed |
FMR1NB | Fragile X mental retardation 1 neighbor | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
FN1 | Fibronectin 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
FXYD5 | FXYD domain containing ion transport regulator 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
GANAB | Glucosidase, alpha; neutral AB | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GNAS | GNAS complex locus | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
GNS | Glucosamine (N-acetyl)-6-sulfatase | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
GOLM1 | Golgi membrane protein 1 | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GPD2 | Glycerol-3-phosphate dehydrogenase 2 (mitochondrial) | Enzymes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GSN | Gelsolin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GTPBP10 | GTP-binding protein 10 (putative) | Predicted secreted proteins
| | | | | Expressed in all |
H6PD | Hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
HSD17B11 | Hydroxysteroid (17-beta) dehydrogenase 11 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
HSP90B1 | Heat shock protein 90kDa beta (Grp94), member 1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
HSPA5 | Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
HSPA9 | Heat shock 70kDa protein 9 (mortalin) | Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
HTATIP2 | HIV-1 Tat interactive protein 2, 30kDa | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ICAM1 | Intercellular adhesion molecule 1 | Cancer-related genes Candidate cardiovascular disease genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ICAM3 | Intercellular adhesion molecule 3 | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IGFLR1 | IGF-like family receptor 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ITGA3 | Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ITGA5 | Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ITGB1 | Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAMA4 | Laminin, alpha 4 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |